Escalation
Showing 26 - 50 of >10,000
Oropharyngeal Cancer, Squamous Cell Carcinoma of the Oropharynx Trial in Ann Arbor (procedure, combination product, other,
Recruiting
- Oropharyngeal Cancer
- Squamous Cell Carcinoma of the Oropharynx
- Surgery
- +3 more
-
Ann Arbor, MichiganUniversity of Michigan Rogel Cancer Center
May 30, 2023
Acute Coronary Syndrome Trial in Muncie (MT1002 for Injection)
Recruiting
- Acute Coronary Syndrome
- MT1002 for Injection
-
Muncie, IndianaBruce Graham
Jan 23, 2023
Head and Neck Carcinoma Trial in Cairo (Elective nodal de-escalation arm)
Recruiting
- Head and Neck Carcinoma
- Elective nodal de-escalation arm
-
Cairo, EgyptNational Cancer Institute
Dec 6, 2022
HPV Infection, HPV-Related Cervical Carcinoma Trial (FluBHPVE6E7, Placebo)
Not yet recruiting
- HPV Infection
- HPV-Related Cervical Carcinoma
- FluBHPVE6E7
- Placebo
- (no location specified)
Apr 24, 2023
Liver Cancer, Hepatocellular Carcinoma Trial (Regorafenib Oral Product)
Not yet recruiting
- Liver Cancer
- Hepatocellular Carcinoma
- Regorafenib Oral Product
- (no location specified)
Nov 17, 2022
Prostate Adenocarcinoma Trial (De-escalated radiotherapy to be delivered on the Elekta Unity Unity MR-linac)
Not yet recruiting
- Prostate Adenocarcinoma
- De-escalated radiotherapy to be delivered on the Elekta Unity Unity MR-linac
- (no location specified)
Jan 23, 2023
Ventilator Associated Pneumonia Trial (cotrimoxazole, standard antibiotic therapy)
Not yet recruiting
- Ventilator Associated Pneumonia
- cotrimoxazole
- standard antibiotic therapy
- (no location specified)
Jan 23, 2023
Locally Advanced/Metastatic Solid Tumors Trial in Newport Beach, San Diego, Canton (FL115)
Active, not recruiting
- Locally Advanced/Metastatic Solid Tumors
-
Newport Beach, California
- +2 more
Nov 10, 2023
Message Exposure Trial in Athens (educational message exposure)
Not yet recruiting
- Message Exposure
- educational message exposure
-
Athens, GeorgiaUGA Bio-imaging Research Center
Apr 13, 2023
Facet Joints; Degeneration, Back Pain, Facet Joint Pain Trial (Alocyte low dose, Alocyte medium dose, Alocyte high dose)
Not yet recruiting
- Facet Joints; Degeneration
- +2 more
- Alocyte low dose
- +2 more
- (no location specified)
Jun 8, 2023
Solid Tumor, Adult Trial in Belgium, France (DT-9081 - dose escalation, DT-9081 - expansion)
Recruiting
- Solid Tumor, Adult
- DT-9081 - dose escalation
- DT-9081 - expansion
-
Anderlecht, Belgium
- +3 more
Jan 5, 2023
Non-hodgkin Lymphoma Trial (CD38-SADA:177Lu-DOTA Complex)
Not yet recruiting
- Non-hodgkin Lymphoma
- CD38-SADA:177Lu-DOTA Complex
- (no location specified)
Aug 15, 2023
Coronary Artery Disease, Coronary Artery Bypass Grafting, Dual Antiplatelet Therapy Trial in Beijing (De-escalated Dual
Recruiting
- Coronary Artery Disease
- +6 more
- De-escalated Dual Antiplatelet Therapy
- Dual Antiplatelet Therapy
-
Beijing, ChinaFuwai Hospital
Dec 13, 2022
Prostatic Tumors, Castration-Resistant Trial in Brisbane ([212Pb]Pb-ADVC001)
Not yet recruiting
- Prostatic Neoplasms
- Castration-Resistant
-
Brisbane, Queensland, AustraliaRoyal Brisbane & Women's Hospital
Feb 9, 2023
Astrocytoma, Grade IV, Giant Cell Glioblastoma, Glioblastoma Multiforme Trial run by the NCI (Radiation)
Active, not recruiting
- Astrocytoma, Grade IV
- +3 more
- Radiation
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 26, 2023
Advanced Solid Tumor Trial in Nijmegen (PRECIOUS-01)
Recruiting
- Advanced Solid Tumor
-
Nijmegen, Gelderland, NetherlandsRadboudumc
Oct 26, 2022
Ovarian Cancer Trial in Lexington (Lapatinib and Paclitaxel)
Recruiting
- Ovarian Cancer
- Lapatinib and Paclitaxel
-
Lexington, KentuckyMarkey Cancer Center
Dec 2, 2022
Acute Myeloid Leukemia (AML) Trial in Nantes (Siltuximab)
Not yet recruiting
- Acute Myeloid Leukemia (AML)
-
Nantes, FranceCHU de Nantes
Jan 24, 2023
Ovarian Cancer Trial in Lexington (Artemisia annua 450mg, Artemisia annua 900mg, Artemisia annua 1350mg)
Recruiting
- Ovarian Cancer
- Artemisia annua 450mg
- +4 more
-
Lexington, KentuckyUniversity of Kentucky
Jan 4, 2023
Colon Cancer Trial in Qingdao (Chimeric antigen receptor T cell preparation targeting GCC)
Recruiting
- Colon Cancer
- Chimeric antigen receptor T cell preparation targeting GCC
-
Qingdao, Shandong, ChinaThe Affiliated Hospital of Qingdao University
May 16, 2023
Pain, Postoperative Trial in Seongnam-si (GB-6002, Placebo, Naropin injection)
Recruiting
- Pain, Postoperative
- GB-6002
- +2 more
-
Seongnam-si, Korea, Republic ofSeoul National University Bundang Hospital
Oct 17, 2023
Cardiorenal Syndrome Type 1 Trial in Mexico City (Diuretic de/escalation based on ultrasound findings (VExUS Score), Diuretic
Recruiting
- Cardiorenal Syndrome Type 1
- Diuretic de/escalation based on ultrasound findings (VExUS Score)
- Diuretic de/escalation based on clinical findings (CCS Score)
-
Mexico City, MexicoInstituto Nacional de Cardiología Ignacio Chávez
Oct 3, 2023